IBDEI1AC ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23062,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23062,1,3,0)
 ;;=3^SCC EYELID/CANTHUS
 ;;^UTILITY(U,$J,358.3,23062,1,4,0)
 ;;=4^173.12
 ;;^UTILITY(U,$J,358.3,23062,2)
 ;;=^340468
 ;;^UTILITY(U,$J,358.3,23063,0)
 ;;=173.19^^135^1389^74
 ;;^UTILITY(U,$J,358.3,23063,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23063,1,3,0)
 ;;=3^MAL NEO EYELID/CANTH NEC
 ;;^UTILITY(U,$J,358.3,23063,1,4,0)
 ;;=4^173.19
 ;;^UTILITY(U,$J,358.3,23063,2)
 ;;=^340469
 ;;^UTILITY(U,$J,358.3,23064,0)
 ;;=173.90^^135^1389^84
 ;;^UTILITY(U,$J,358.3,23064,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23064,1,3,0)
 ;;=3^MAL NEO SKIN SITE NOS
 ;;^UTILITY(U,$J,358.3,23064,1,4,0)
 ;;=4^173.90
 ;;^UTILITY(U,$J,358.3,23064,2)
 ;;=^340605
 ;;^UTILITY(U,$J,358.3,23065,0)
 ;;=173.91^^135^1389^11
 ;;^UTILITY(U,$J,358.3,23065,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23065,1,3,0)
 ;;=3^BCC SKIN NOS
 ;;^UTILITY(U,$J,358.3,23065,1,4,0)
 ;;=4^173.91
 ;;^UTILITY(U,$J,358.3,23065,2)
 ;;=^340491
 ;;^UTILITY(U,$J,358.3,23066,0)
 ;;=173.92^^135^1389^128
 ;;^UTILITY(U,$J,358.3,23066,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23066,1,3,0)
 ;;=3^SCC SKIN NOS
 ;;^UTILITY(U,$J,358.3,23066,1,4,0)
 ;;=4^173.92
 ;;^UTILITY(U,$J,358.3,23066,2)
 ;;=^340492
 ;;^UTILITY(U,$J,358.3,23067,0)
 ;;=173.99^^135^1389^85
 ;;^UTILITY(U,$J,358.3,23067,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23067,1,3,0)
 ;;=3^MAL NEO SKIN,SITE UNSPEC
 ;;^UTILITY(U,$J,358.3,23067,1,4,0)
 ;;=4^173.99
 ;;^UTILITY(U,$J,358.3,23067,2)
 ;;=^340493
 ;;^UTILITY(U,$J,358.3,23068,0)
 ;;=171.9^^135^1389^88
 ;;^UTILITY(U,$J,358.3,23068,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23068,1,3,0)
 ;;=3^MAL NEO SOFT TISSUE NOS
 ;;^UTILITY(U,$J,358.3,23068,1,4,0)
 ;;=4^171.9
 ;;^UTILITY(U,$J,358.3,23068,2)
 ;;=^267165
 ;;^UTILITY(U,$J,358.3,23069,0)
 ;;=173.49^^135^1389^80
 ;;^UTILITY(U,$J,358.3,23069,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23069,1,3,0)
 ;;=3^MAL NEO SCLP/SKN NCK NEC
 ;;^UTILITY(U,$J,358.3,23069,1,4,0)
 ;;=4^173.49
 ;;^UTILITY(U,$J,358.3,23069,2)
 ;;=^340478
 ;;^UTILITY(U,$J,358.3,23070,0)
 ;;=173.41^^135^1389^9
 ;;^UTILITY(U,$J,358.3,23070,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23070,1,3,0)
 ;;=3^BCC SCALP/SKIN NECK
 ;;^UTILITY(U,$J,358.3,23070,1,4,0)
 ;;=4^173.41
 ;;^UTILITY(U,$J,358.3,23070,2)
 ;;=^340476
 ;;^UTILITY(U,$J,358.3,23071,0)
 ;;=173.42^^135^1389^126
 ;;^UTILITY(U,$J,358.3,23071,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23071,1,3,0)
 ;;=3^SCC SCALP/SKIN NECK
 ;;^UTILITY(U,$J,358.3,23071,1,4,0)
 ;;=4^173.42
 ;;^UTILITY(U,$J,358.3,23071,2)
 ;;=^340477
 ;;^UTILITY(U,$J,358.3,23072,0)
 ;;=173.40^^135^1389^81
 ;;^UTILITY(U,$J,358.3,23072,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23072,1,3,0)
 ;;=3^MAL NEO SCLP/SKN NCK NOS
 ;;^UTILITY(U,$J,358.3,23072,1,4,0)
 ;;=4^173.40
 ;;^UTILITY(U,$J,358.3,23072,2)
 ;;=^340600
 ;;^UTILITY(U,$J,358.3,23073,0)
 ;;=11000^^136^1390^1^^^^1
 ;;^UTILITY(U,$J,358.3,23073,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23073,1,2,0)
 ;;=2^11000
 ;;^UTILITY(U,$J,358.3,23073,1,3,0)
 ;;=3^Debride ext eczematous skin,<10%
 ;;^UTILITY(U,$J,358.3,23074,0)
 ;;=11001^^136^1390^2^^^^1
 ;;^UTILITY(U,$J,358.3,23074,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23074,1,2,0)
 ;;=2^11001
 ;;^UTILITY(U,$J,358.3,23074,1,3,0)
 ;;=3^Debride ext eczematous skin,Ea 10%
 ;;^UTILITY(U,$J,358.3,23075,0)
 ;;=11042^^136^1390^3^^^^1
 ;;^UTILITY(U,$J,358.3,23075,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,23075,1,2,0)
 ;;=2^11042
 ;;^UTILITY(U,$J,358.3,23075,1,3,0)
 ;;=3^Debride Subcut (epi/derm);20sq cm or <
 ;;^UTILITY(U,$J,358.3,23076,0)
 ;;=11045^^136^1390^4^^^^1
